Skip to main content

Contineum Therapeutics

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical enterprise headquartered in San Diego, California. The company specializes in the discovery and development of novel small-molecule therapeutics targeting specialized biological pathways for the treatment of neuroscience, inflammation, and autoimmune conditions. Its proprietary research engine designs selective oral medications to address unmet medical needs. Principal revenue is currently earned through strategic pharmaceutical partnerships, research collaborations, and capital financing arrangements as its drug candidates advance through clinical development. Contineum Therapeutics Inc is publicly listed on the Nasdaq Stock Market.

2 of the funds FundTelligence covers report a position in Contineum Therapeutics.

Legal name
Contineum Therapeutics Inc
Sector
Health Care
Country
United States
Funds holding it
2

Funds holding Contineum Therapeutics

Loading...